-
Capsaicin, Autophagy, and BMSC Protection Under Stress
2026-08-22
The reference study identifies a TRPV1–Ca2+–autophagy axis through which capsaicin preserves rat bone marrow stromal cell viability and osteogenic function during hydrogen peroxide-induced oxidative stress. Its main contribution is to connect calcium signaling with suppression of PI3K/AKT/mTOR phosphorylation, while also highlighting the need for causal pathway controls before translation to osteoporosis therapy.
-
TAK-242 (Resatorvid): TLR4 Inhibition Guide
2026-08-21
TAK-242, also called Resatorvid, is a selective small-molecule inhibitor of intracellular TLR4 signaling. It is used to investigate LPS-driven inflammatory mediator production, neuroinflammation, and TLR4-dependent pathway suppression in preclinical systems.
-
Cy5-UTP for Mechanistic RNA-LNP Translation
2026-08-20
A translational framework for using Cy5-UTP to connect RNA probe synthesis, fluorescent tracking, and lipid nanoparticle design without confusing fluorescence with functional mRNA delivery.
-
MCL-1 Dependence in Breast Cancer: What the Study Shows
2026-08-20
The reference study establishes that established breast tumors depend on MCL-1 primarily because of its canonical anti-apoptotic control of BAX/BAK-mediated mitochondrial death. By combining acute genetic deletion, selective pharmacological inhibition, and BAX/BAK epistasis, the work connects MCL-1 dependency to tumor maintenance and provides a mechanistic framework for apoptosis-focused cancer research.
-
Erastin Enhances Oncolytic Virus Immunotherapy
2026-08-19
The reference study shows that combining the ferroptosis inducer Erastin with an oncolytic vaccinia virus produced stronger tumor control than either treatment alone in hepatocellular carcinoma and colon cancer models. Its main contribution is to connect ferroptotic tumor-cell damage with enhanced dendritic-cell activation and tumor-infiltrating CD8+ T-cell activity, while also revealing substantial tumor-type dependence.
-
Bifendate (DDB): From Mechanism to Translation
2026-08-19
A mechanism-first perspective on Bifendate (DDB) for translational liver research, connecting hepatoprotection, regulation of lipid metabolism, autophagy inhibition, experimental design, formulation, drug-interaction risk, and the strategic limits of extending these findings into liver-oncology models.
-
Benzyl-activated Streptavidin Magnetic Beads for HBV Entry
2026-08-18
Benzyl-activated Streptavidin Magnetic Beads can convert complex HBV entry biology into controlled capture and interaction assays. This guide connects CDC42–NTCP trafficking research with practical decisions for pathway-resolved protein and nucleic acid workflows.
-
RIPA Lysis Buffer (Strong) for Glioma Protein Studies
2026-08-18
RIPA Lysis Buffer (Strong) supports reproducible protein extraction from glioma cells and tissues for Western blotting, immunoprecipitation, and pathway validation. This practical guide connects robust lysate preparation with the CSRP2–PDGFRA–PI3K/AKT findings reported in a recent glioma study while highlighting when strong detergent extraction should be modified or avoided.
-
TSPAN18-STIM1 Signaling in Prostate Cancer Bone Metastasis
2026-08-17
Zhou et al. identify TSPAN18 as a regulator of STIM1 protein stability and connect this interaction to calcium entry, prostate cancer cell invasiveness, and bone metastasis. The study integrates proteomic, biochemical, cell-based, animal, and clinical analyses, providing a mechanistic framework for investigating STIM1 turnover rather than treating calcium signaling as an isolated downstream event.
-
Mithramycin A Workflows for Transcription Research
2026-08-17
Mithramycin A turns metal-dependent binding to G-C-rich DNA into a practical strategy for probing c-myc regulation, transcription, and myeloid differentiation. This workflow-focused guide connects leukemia and cancer biology research with carefully bounded insights from a cardiac injury study, emphasizing controls, orthogonal readouts, and troubleshooting.
-
ZK53 and the Translational Logic of Human ClpP Activation
2026-08-16
ZK53 is a selective human mitochondrial serine protease ClpP activator that connects mitochondrial proteostasis, oxidative phosphorylation failure, DNA damage signaling, cell-cycle control, and ferroptosis sensitization. This thought-leadership perspective outlines how translational researchers can validate mechanism, choose models, interpret assay differences, and build a disciplined preclinical development strategy.
-
WIP1-p38 MAPK Control of Pyroptosis in Septic AKI
2026-08-15
The reference study identifies WIP1/PPM1D as a negative regulator of p38 MAPK-driven renal tubular pyroptosis in sepsis-associated acute kidney injury. By combining transcriptomic, human tissue, cell, and mouse evidence, it shows that pharmacological WIP1 inhibition with CCT007093 intensifies p38 phosphorylation and pyroptotic injury.
-
Ibrutinib (PCI-32765): A BTK Assay Strategy
2026-08-15
Explore how Ibrutinib (PCI-32765) can sharpen BTK pathway experiments through covalent target engagement, dose–time design, and orthogonal readouts. This article also translates assay-design lessons from an olive-biophenol Alzheimer’s study without conflating distinct disease mechanisms.
-
Brain-to-Spinal Control of Mechanical Allodynia
2026-08-14
Huo et al. identified a contralateral lPBN Oprm1–dmH Pdyn–spinal dorsal horn pathway that limits the spread and persistence of mechanical allodynia in mice. The study separates the neural control of pain laterality from pain duration and provides a circuit-level framework for interpreting bilateral hypersensitivity after injury.
-
GW4064: From FXR Activation to Assay Insight
2026-08-14
GW4064 is a non-steroidal FXR agonist for dissecting receptor activity, bile acid transport, and lipid phenotypes. This guide connects potency measurements with functional assay design and interprets the compound through recent evidence on FXR-mediated cholestatic injury.
450 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page